This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of selegiline
PDMED_SELEGILINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1753 |
4. Check minimum number of events
Min. number of events
3
|
1753 |
5. Include endpointsNone |
1753 |
6. Filter based on genotype QC (FinnGen only) |
1725 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of selegiline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1725 | 725 | 1000 |
| Unadjusted period prevalence (%) | 0.37 | 0.26 | 0.46 |
| Median age at first event (years) | 64.81 | 63.55 | 65.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1753
- Matched controls
- 17530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
121.3
307.7
310
31
N04BC09
ATC
rotigotine; transdermal
164.2
307.7
241
17
193
Kela drug reimbursment
Rasagiline
326.0
307.7
458
19
N04BC04
ATC
ropinirole; oral
205.8
307.7
633
48
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
321.7
307.7
743
40
N04BB01
ATC
amantadine; oral
34.8
307.7
244
81
N04BX02
ATC
entacapone; oral
257.3
307.7
299
14
G20
ICD-10 Finland
Parkinson disease
793.2
307.7
1619
263
N87
ICPC
Parkinsonism
123.5
307.7
687
91
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
1071.1
307.7
1632
218
N04BD02
ATC
rasagiline; oral
347.8
307.7
566
24
N04BD01
ATC
selegiline; oral
+∞
307.7
1753
34
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
418.7
307.7
1560
332
N04BC05
ATC
pramipexole; oral
28.9
307.7
985
744
R25.1
ICD-10 Finland
Tremor, unspecified
12.7
269.0
281
260
N06DA03
ATC
rivastigmine; oral, transdermal
8.9
258.3
362
498
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
27.9
252.7
174
69
N03AE01
ATC
clonazepam; systemic
7.8
202.3
311
471
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
44.1
160.8
96
23
N05AH04
ATC
quetiapine; oral
4.4
160.7
520
1530
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
200.8
159.8
164
9
N04AA02
ATC
biperiden; systemic
14.3
153.4
143
108
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
78.2
153.0
82
11
N04BC06
ATC
cabergoline; oral
46.4
142.5
84
19
G04BD12
ATC
mirabegron; oral
3.8
119.2
447
1432
H02AA02
ATC
fludrocortisone; oral
16.4
117.9
101
65
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
145.6
115.7
122
9
G02CB01
ATC
bromocriptine; systemic
15.2
97.8
87
60
N04BX04
ATC
opicapone; oral
205.2
94.4
97
5
XA800
NOMESCO Finland
Neuropsychological investigation
6.4
91.8
161
274
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
28.2
88.6
60
22
N19
ICPC
Speech disorder
11.2
85.9
92
86
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.0
85.1
273
772
N04BC02
ATC
pergolide; oral
427.1
82.7
82
*
R1250
NOMESCO Finland
Evaluation of functional capability
7.7
82.5
119
164
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
15.6
82.3
72
48
SPAT1229
SPAT
Assessment of need for aid
3.7
80.3
290
889
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
9.4
68.5
83
92
XF606
NOMESCO Finland
Ortostatic test
13.5
62.4
59
45
C07AA05
ATC
propranolol; systemic
2.7
61.9
416
1810
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.7
60.6
210
621
I95.1
ICD-10 Finland
Orthostatic hypotension
4.2
60.2
171
439
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
130.6
59.2
63
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
56.5
658
3657
R4130
NOMESCO Finland
Speech therapy
5.8
56.4
106
192
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
122.0
55.1
59
5
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
52.5
141
346
AA1AD
NOMESCO Finland
CT of head and brain
2.2
49.7
664
3857
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
48.5
414
1993
A06AD11
ATC
lactulose; oral
2.3
44.5
432
2190
Z2445
NOMESCO Finland
Psychologist
5.2
44.3
94
190
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
44.2
199
690
L28
ICPC
Limited function/disability (L)
2.2
42.4
452
2375
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.1
42.0
91
187
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
41.7
95
204
N29
ICPC
Neurological sympt/complt other
5.7
40.4
77
141
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.1
39.6
60
87
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.0
39.1
185
658
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.4
38.9
146
452
SPAT1216
SPAT
Assessment of functional ability
2.2
38.3
397
2054
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.2
37.9
161
538
D21
ICPC
Swallowing problem
5.8
37.5
69
122
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
36.6
144
459
R53
ICD-10 Finland
Malaise and fatigue
2.0
35.0
482
2764
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.7
35.0
56
86
A28
ICPC
Limited function/disability NOS
2.0
33.3
439
2473
N28
ICPC
Limited function/disability (N)
5.2
33.1
69
137
U04
ICPC
Incontinence urine
3.0
33.0
160
576
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
13.1
32.3
31
24
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.2
32.0
87
215
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
8.3
30.4
40
49
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
29.5
181
736
SPAT1234
SPAT
Support of social functional capacity
2.8
28.7
149
556
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
28.7
647
4304
N04BC01
ATC
bromocriptine; oral
101.7
27.7
30
*
G25.2
ICD-10 Finland
Other specified forms of tremor
8.7
27.6
35
41
G35
ICD-10 Finland
Multiple sclerosis
7.3
27.2
40
56
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
27.1
179
754
M48.0
ICD-10 Finland
Spinal stenosis
2.1
26.2
301
1598
N05BA04
ATC
oxazepam; oral
1.8
25.9
482
3009
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
25.8
439
2665
R1260
NOMESCO Finland
Evaluation of communicative skills
4.4
25.7
65
152
R44.1
ICD-10 Finland
Visual hallucinations
8.8
25.4
32
37
R60.0
ICD-10 Finland
Localized oedema
2.1
25.2
270
1396
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
25.0
346
1960
N03AX12
ATC
[U] gabapentin; oral
2.0
24.4
323
1801
N06AX11
ATC
mirtazapine; oral
1.7
24.4
592
3982
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
24.1
195
900
N04BC07
ATC
apomorphine; parenteral
+∞
24.0
23
*
R35
ICD-10 Finland
Polyuria
2.4
23.9
170
741
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
22.9
325
1851
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.6
22.5
43
79
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.6
22.0
52
115
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
21.9
21
*
N86
ICPC
Multiple sclerosis
17.3
21.8
34
20
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.6
21.1
40
73
S01.0
ICD-10 Finland
Open wound of scalp
2.2
20.9
188
904
N04BX01
ATC
tolcapone; oral
+∞
20.9
20
*
R5110, ,
SPAT
2.4
20.8
152
670
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
30.4
20.6
27
9
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.3
20.0
76
237
Z50.5
ICD-10 Finland
Speech therapy
5.7
20.0
37
66
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
19.3
85
289
G04BD09
ATC
trospium; oral
3.4
19.3
69
207
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
19.1
157
727
AA5QN, ,
NOMESCO Finland
101.1
18.6
20
*
C01CA01
ATC
etilefrine; systemic
5.8
18.5
34
60
K59.0
ICD-10 Finland
Constipation
2.4
18.5
134
587
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
18.2
63
185
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
14.5
18.1
30
21
N30.0
ICD-10 Finland
Acute cystitis
1.8
17.6
277
1622
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
96.0
17.6
19
*
R23
ICPC
Voice symptom/complaint
4.1
17.0
47
118
G04BD11
ATC
fesoterodine; oral
3.1
16.9
71
235
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
16.9
123
541
N06AB10
ATC
escitalopram; oral
1.8
16.8
270
1589
S72.0
ICD-10 Finland
Fracture of neck of femur
2.4
16.7
124
549
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.9
16.7
36
74
W19
ICD-10 Finland
Unspecified fall
2.0
16.6
193
1021
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
7.4
16.5
24
33
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
40.5
16.3
20
5
N99
ICPC
Neurological disease other
4.3
16.0
41
97
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.2
16.0
64
206
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.1
16.0
44
110
H50.52
ICD-10 Finland
Exophoria
5.8
15.9
29
51
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
15.9
98
399
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.5
15.7
30
55
F0232, G20,
ICD-10 Finland
85.9
15.6
17
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
15.3
817
9946
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
14.8
134
2560
130
Kela drug reimbursment
Malignant tumour
0.2
14.6
29
1117
J01EA01
ATC
trimethoprim; systemic
1.6
14.5
444
3095
G25.0
ICD-10 Finland
Essential tremor
2.9
14.4
66
230
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
10.5
14.2
27
26
N06BA07
ATC
modafinil; oral
42.8
14.1
17
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.2
13.9
117
547
G90.3
ICD-10 Finland
Multi-system degeneration
30.3
13.9
18
6
AA1AA
NOMESCO Finland
Head X-ray examination
5.2
13.6
28
55
F0230, G20,
ICD-10 Finland
75.7
13.6
15
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
13.6
184
1024
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.6
13.5
80
320
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.0
13.3
60
208
N04AA01
ATC
trihexyphenidyl; oral
40.4
13.2
16
*
L03
ICPC
Low back symptom/complaint
1.6
13.1
408
2844
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.1
12.9
53
174
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
12.8
175
976
S70.0
ICD-10 Finland
Contusion of hip
2.4
12.7
87
372
SPAT1167
SPAT
Insertion of urinary catheter
2.5
12.7
83
348
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
12.6
210
1245
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
12.6
288
1863
M54.5
ICD-10 Finland
Low back pain
1.5
12.5
521
3861
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
12.5
114
550
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.2
12.5
21
34
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
12.4
58
205
G04BD08
ATC
solifenacin; oral
2.0
12.4
139
726
M03BX01
ATC
baclofen; systemic
3.4
12.4
44
132
R4110, ,
SPAT
1.9
12.3
154
835
C10AA05
ATC
atorvastatin; oral
0.7
12.2
481
6324
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
4.5
12.1
29
65
XKC03
NOMESCO Finland
Water cystometry
2.7
12.0
65
249
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
11.6
169
963
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.4
11.5
28
64
A04
ICPC
Weakness/tiredness general
1.7
11.4
249
1588
UKC02
NOMESCO Finland
Cystoscopy
1.6
11.4
339
2330
F0234, G20,
ICD-10 Finland
120.8
11.4
12
*
R13
ICD-10 Finland
Dysphagia
1.9
11.4
136
725
N06AB04
ATC
citalopram; systemic
1.6
11.4
339
2333
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
11.3
72
298
XKD00
NOMESCO Finland
Uroflowmetry
1.6
11.2
344
2381
N05AH02
ATC
clozapine; systemic
4.5
11.2
27
61
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.2
11.1
43
136
G04BD07
ATC
tolterodine; oral
2.1
11.1
106
522
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
11.1
291
1945
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
11.0
254
1643
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
10.9
261
1703
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.4
10.9
71
297
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
10.9
132
708
Z75.5
ICD-10 Finland
Holiday relief care
3.7
10.8
34
94
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
10.7
518
3936
SPAT1172
SPAT
Guidance concerning hydration
2.8
10.6
54
200
G04BD04
ATC
oxybutynin; oral, transdermal
2.0
10.6
118
614
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
10.4
10
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
10.4
10
*
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.8
10.2
50
182
R1250, ,
SPAT
3.4
10.2
35
103
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
4.8
10.0
22
46
R30.1
ICD-10 Finland
Vesical tenesmus
3.0
10.0
42
140
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
10.0
74
329
L84
ICD-10 Finland
Corns and callosities
2.4
9.7
66
282
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.3
9.7
72
320
SPAT1254
SPAT
Administration of medicine
1.6
9.7
264
1776
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
55.3
9.7
11
*
N06AX03
ATC
mianserin; oral
2.1
9.5
90
442
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
9.5
245
1627
R33
ICD-10 Finland
Retention of urine
1.7
9.4
186
1155
34200
ICD-8 Finland
Paralysis agitans, Parkinsonismus
100.6
9.4
10
*
M41.5
ICD-10 Finland
Other secondary scoliosis
17.6
9.4
14
8
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
9.4
179
1101
R55
ICD-10 Finland
Syncope and collapse
1.6
9.4
210
1347
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
9.4
73
1481
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
21.8
9.4
13
6
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.3
778
6452
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
9.3
124
687
K56.2
ICD-10 Finland
Volvulus
4.1
9.3
25
62
H02AB02
ATC
dexamethasone; systemic
0.4
9.2
56
1248
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.7
9.1
49
187
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
11.5
9.1
16
14
L76
ICPC
Fracture: other
2.4
9.0
60
254
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
10.1
9.0
17
17
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
9.0
157
942
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.9
8.9
41
144
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
18.7
8.9
13
7
S63.1
ICD-10 Finland
Dislocation of finger
3.2
8.9
34
107
F05.9
ICD-10 Finland
Delirium, unspecified
2.6
8.8
51
202
RF120, ,
NOMESCO Finland
3.6
8.8
28
78
359
Kela drug reimbursment
Mirabegroni
4.9
8.8
19
39
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.3
8.8
32
98
R4120, ,
SPAT
4.4
8.6
21
48
C10AX09
ATC
ezetimibe; oral
0.5
8.6
109
1894
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
8.5
293
4023
H50.31
ICD-10 Finland
Intermittent exotropia
7.4
8.4
19
26
C08CA01
ATC
amlodipine; oral
0.7
8.4
464
5857
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
12.8
8.4
14
11
G21.8
ICD-10 Finland
Other secondary parkinsonism
12.8
8.4
14
11
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.9
8.4
18
37
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
8.3
8
*
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
8.3
8
*
K03.66
ICD-10 Finland
Tooth plaque
1.8
8.3
114
637
R5130, ,
SPAT
9.5
8.3
16
17
ZXY02
NOMESCO Finland
Neuropsychologist
9.5
8.3
16
17
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.4
8.2
55
234
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
14.5
8.2
13
9
C10AA07
ATC
rosuvastatin; oral
0.7
8.2
292
3984
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
8.1
108
598
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.0
430
3301
N06AX21
ATC
duloxetine; oral
1.7
7.9
158
985
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
7.9
168
1064
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
7.8
234
3305
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
7.7
223
3175
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
4.5
7.7
18
40
N02BF01
ATC
gabapentin; oral
1.7
7.7
125
737
K08.3
ICD-10 Finland
Retained dental root
1.7
7.6
129
768
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
7.6
292
2106
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.5
682
5670
SCA02
NOMESCO Finland
Preventive oral health care
1.8
7.5
114
659
T08
ICPC
Weight loss
2.9
7.4
33
114
214
Kela drug reimbursment
Severe and chronic narcolepsy
80.4
7.4
8
*
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
80.4
7.4
8
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.4
7.4
30
793
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
7.4
59
272
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.5
7.4
45
184
N04C02, ,
ATC
+∞
7.3
7
*
OAB73, ,
SPAT
9.4
7.3
14
15
R44.3
ICD-10 Finland
Hallucinations, unspecified
5.8
7.2
19
33
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
7.1
44
181
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
7.1
93
513
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
2.9
7.1
32
112
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
7.1
39
902
WX290
NOMESCO Finland
Other blockage of nerve
1.3
7.1
536
4334
N08
ICPC
Abnormal involuntary movements
8.8
7.0
14
16
RF410, ,
NOMESCO Finland
3.2
7.0
26
81
S06.0
ICD-10 Finland
Concussion
1.6
7.0
165
1073
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
6.9
96
540
RF420, ,
NOMESCO Finland
3.1
6.9
28
92
TKC22
NOMESCO Finland
Catheterisation instruction
2.3
6.9
52
234
R5599
NOMESCO Finland
Other rehabilitation service
2.3
6.9
49
215
R1420, ,
SPAT
13.8
6.9
11
8
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
6.8
209
1439
N06AX16
ATC
venlafaxine; oral
1.6
6.8
165
1078
A10BA02
ATC
metformin; oral
0.7
6.8
312
4093
Z3226
NOMESCO Finland
Physiotherapist
1.4
6.8
290
2131
SPAT1125
SPAT
Stoma care and guidance
2.6
6.8
37
143
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.3
6.8
48
210
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.5
6.8
41
167
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
6.8
264
1909
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
6.8
77
406
R41.0
ICD-10 Finland
Disorientation, unspecified
2.0
6.7
66
330
SPAT1244
SPAT
Occupational therapy
3.4
6.7
23
68
S22.3
ICD-10 Finland
Fracture of rib
1.7
6.7
127
781
L75
ICPC
Fracture: femur
2.8
6.7
32
116
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.9
6.6
81
437
L01BC06
ATC
capecitabine; oral
0.2
6.6
9
366
M04AA01
ATC
allopurinol; systemic
0.6
6.6
126
1971
A04AA55
ATC
palonosetron, combinations; systemic
0.1
6.5
*
244
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
6.5
38
152
T90
ICPC
Diabetes non-insulin dependent
0.7
6.5
234
3208
J01CA08
ATC
pivmecillinam; oral
1.3
6.5
510
4135
Y94.0
ICD-10 Finland
Accident at home
2.6
6.5
36
141
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.4
128
797
L95
ICPC
Osteoporosis
2.0
6.4
64
322
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
2.4
6.4
42
178
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.1
6.3
25
81
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
6.0
6.3
16
27
SFE01
NOMESCO Finland
Carriage renovation
11.1
6.3
11
10
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.0
6.3
27
92
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
6.2
209
1467
N06BA04
ATC
methylphenidate; oral
5.0
6.2
18
36
SFA10
NOMESCO Finland
One-surface restoration
1.3
6.1
719
6145
K04.1
ICD-10 Finland
Necrosis of pulp
1.6
6.1
136
872
PA2AD
NOMESCO Finland
CT angiography of brain
3.8
6.1
18
48
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
6.1
10
428
R1100, ,
SPAT
6.7
6.0
14
21
H53.2
ICD-10 Finland
Diplopia
2.1
6.0
55
268
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
10.1
6.0
11
11
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
6.0
68
358
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.0
6.0
66
344
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
41
12.78
52.23
1.7
1.3
83.38
141.88
nmol/l
1.02
29
30
618
4642
1.51
14.33
2.4
2.2
234.33
228.56
u/l
0.06
575
4327
1150
13001
0.66
13.89
4.0
4.8
4.45
4.48
mmol/l
0.54
1009
11786
1137
12878
0.67
13.79
4.1
4.7
1.47
1.44
mmol/l
1.42
990
11572
1191
13353
0.66
13.54
4.5
5.4
2.60
2.60
mmol/l
0.01
1041
12024
349
4928
0.64
12.60
3.7
3.9
5.18
8.84
mg/mmol
3.56
235
3123
1100
12471
0.68
12.57
3.6
4.2
1.13
1.29
mmol/l
17.77
947
11100
35
89
3.99
12.47
2.9
2.4
—
—
—
0
0
330
4655
0.64
11.65
3.0
3.3
277.10
274.31
mg/l
0.00
218
3004
339
4726
0.65
11.24
2.9
3.2
8.11
7.32
mmol/l
2.70
278
3901
288
1936
1.58
10.65
7.9
8.1
—
—
—
0
0
497
3752
1.45
10.57
1.7
1.6
18.19
20.38
nmol/l
2.87
434
3141
1088
9421
1.41
10.52
6.4
4.9
5537.96
1895.92
e6/l
0.46
23
157
435
3266
1.44
9.35
1.9
1.8
1208.01
1174.35
nmol/l
0.31
320
2423
1146
12679
0.72
9.07
5.8
6.4
39.64
40.86
mmol/mol
4.71
1011
11514
476
3724
1.38
7.88
4.8
4.3
0.00
0.00
estimate
0.69
151
1215
759
6389
1.33
7.76
2.2
2.1
85.38
93.03
pmol/l
6.25
475
3333
262
3606
0.68
7.61
1.5
1.6
1.16
1.34
mmol/l
4.73
205
2950
434
3376
1.38
7.38
1.7
1.7
393.30
13045500.76
pmol/l
1.75
350
2729
804
6940
1.29
6.43
4.6
6.1
1.21
1.21
mmol/l
0.43
705
6271
705
5987
1.30
6.38
4.8
4.1
38.27
57.41
ng/l
1.25
577
4603
1221
13166
0.76
6.18
4.6
5.0
5.92
6.09
mmol/l
6.01
1042
11698
109
1706
0.61
5.72
2.8
4.1
42.34
22.69
ug/l
0.29
82
1437
769
6671
1.27
5.67
4.7
4.0
0.00
0.00
estimate
0.75
169
1384
1019
11188
0.79
5.56
20.6
19.9
15.57
15.39
%
0.38
994
10946
154
1040
1.53
5.53
1.9
1.7
—
—
—
0
0
372
2954
1.33
5.34
5.0
4.5
1.02
1.02
kg/l
0.80
61
448
1330
14104
0.76
5.27
9.3
11.3
18.60
25.61
u/l
14.73
1215
13486
768
6738
1.25
4.91
4.7
4.0
0.00
0.01
estimate
1.08
159
1239
596
5102
1.25
4.68
5.1
4.4
—
—
—
0
0
755
6650
1.24
4.55
6.2
5.4
0.00
0.00
estimate
-0.00
163
1275
1385
14546
0.77
4.48
27.1
24.9
6.61
6.86
e9/l
4.05
1339
14021
1386
14550
0.77
4.41
27.3
25.0
131.11
133.60
g/l
8.22
1359
14240
88
1360
0.63
4.38
1.3
1.3
—
—
—
0
0
1386
14547
0.77
4.38
27.1
24.9
4.35
4.41
e12/l
4.55
1338
14021
1386
14542
0.78
4.32
27.1
24.9
244.97
241.26
e9/l
1.34
1342
14075
1386
14541
0.78
4.30
27.0
25.0
39.09
39.54
%
1.84
1280
13379
357
2907
1.29
4.19
1.8
1.7
1.26
1.44
mg/l
0.82
282
2282
845
7581
1.22
4.13
4.8
6.9
1.21
1.21
mmol/l
0.44
693
6401
1185
12638
0.81
4.12
17.1
16.0
81.23
74.18
ml/min/173m2
31.39
1019
10487
353
4265
0.78
4.00
2.6
3.1
28.62
34.67
u/l
2.81
325
4044
422
3567
1.24
3.56
2.5
2.5
—
—
—
0
0
132
954
1.41
3.43
1.6
1.5
—
—
—
0
0
21
88
2.40
3.40
1.1
1.8
—
—
—
0
0
95
648
1.49
3.35
3.6
4.2
25.53
25.00
mmol/l
1.03
83
598
942
8657
1.19
3.25
4.4
4.9
6.43
6.87
mmol/l
13.89
901
8160
322
2670
1.25
3.21
1.9
1.9
—
—
—
0
0
734
6621
1.19
3.08
2.7
2.7
—
—
—
0
0
143
1074
1.36
2.99
5.4
6.8
25.75
24.53
mmol/l
5.70
136
1023
7
204
0.34
2.80
2.1
1.7
40.97
18.68
ug/l
—
7
199
85
1201
0.69
2.79
1.4
1.7
1.47
1.60
%
0.66
69
998
9
23
3.93
2.77
2.4
2.5
—
—
—
0
0
9
24
3.76
2.67
2.4
2.5
—
—
—
0
0
704
6397
1.17
2.58
2.5
2.4
—
—
—
0
0
234
1919
1.25
2.57
4.2
6.9
5.27
5.10
kpa
2.61
222
1826
234
1920
1.25
2.56
4.2
6.9
12.17
11.83
kpa
0.42
221
1830
88
628
1.42
2.52
1.9
1.8
—
—
—
0
0
234
1926
1.25
2.50
4.3
6.9
1.81
1.13
mmol/l
2.28
195
1507
11
263
0.41
2.34
1.5
1.5
35.28
31.87
g/l
0.45
11
235
230
1906
1.24
2.32
4.2
4.8
34.49
33.02
%
1.22
147
1245
93
687
1.37
2.22
2.0
1.9
—
—
—
0
0
27
153
1.78
2.08
1.1
1.4
222308.95
128332.10
e6/l
0.18
22
105
376
3305
1.18
2.04
2.9
2.7
4.42
4.76
e6/l
0.31
342
2987
19
97
1.97
2.00
1.3
1.5
—
—
—
0
0
115
1465
0.77
1.99
3.8
7.0
9.62
10.91
mmol/l
1.38
108
1385
556
5044
1.15
1.98
2.4
3.4
2.34
2.35
mmol/l
0.29
463
4345
30
487
0.61
1.98
1.3
1.6
—
143.33
—
0
24
19
98
1.95
1.95
1.3
1.4
—
—
—
0
0
205
1720
1.22
1.86
4.5
7.2
95.65
95.24
%
0.50
197
1657
18
329
0.54
1.86
1.1
1.2
1.98
6.47
u/ml
—
6
49
0
54
0.00
1.85
0.0
2.6
—
39940.92
—
0
12
1372
14152
0.86
1.85
21.9
20.0
139.89
139.61
mmol/l
4.07
1337
13736
127
1011
1.28
1.84
3.1
3.8
2.29
2.02
mmol/l
0.36
99
763
1375
14180
0.86
1.84
22.0
20.1
3.96
4.00
mmol/l
8.21
1342
13742
118
1473
0.79
1.76
3.5
3.0
192.06
241.16
ng/l
0.65
106
1351
439
3950
1.15
1.74
2.5
2.2
3.11
3.09
mg/l
0.03
345
3330
158
1904
0.81
1.72
2.9
4.1
240.26
249.65
u/l
0.38
137
1801
55
391
1.42
1.70
1.9
1.7
10681.41
16524.54
e6/l
0.73
41
277
176
2092
0.82
1.68
3.3
5.6
0.99
1.03
mmol/l
1.15
158
1922
46
655
0.69
1.68
1.8
1.8
—
—
—
0
0
23
380
0.60
1.67
1.4
1.5
1.36
17.52
iu/ml
—
8
77
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
11
226
0.48
1.65
1.1
1.1
—
—
—
0
0
131
1066
1.25
1.61
3.3
3.9
5.31
5.17
kpa
1.35
119
1017
11
223
0.49
1.60
1.0
1.2
—
41.85
—
0
19
46
648
0.70
1.59
1.2
1.2
34.48
135.82
iu/ml
6.14
20
230
21
350
0.60
1.59
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
601
0.69
1.58
3.0
2.5
0.46
0.35
u/ml
0.57
24
342
568
5227
1.13
1.58
4.4
3.9
131.24
127.67
e6/l
0.04
416
3893
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
549
5044
1.13
1.57
3.0
3.2
1080.28
1757.45
ng/l
5.48
464
4343
11
221
0.49
1.56
1.1
1.2
—
—
—
0
0
0
42
0.00
1.52
0.0
1.3
—
9.27
—
0
42
5
128
0.39
1.49
1.0
1.2
—
—
—
0
0
10
203
0.49
1.47
1.2
1.2
199.20
288.71
u/ml
—
5
109
16
280
0.57
1.47
1.1
1.3
—
—
—
0
0
11
215
0.51
1.45
1.6
2.6
—
463.56
—
0
16
177
1504
1.20
1.45
2.2
2.5
4.96
7.05
ug/l
1.93
120
1309
23
365
0.63
1.45
1.3
1.2
—
—
—
0
0
350
3885
0.88
1.43
2.2
2.9
6225.72
6829.25
umol/l
0.09
287
3319
600
5567
1.12
1.43
2.2
2.2
74.05
78.71
nmol/l
4.18
502
4833
213
1850
1.17
1.37
1.8
1.8
—
—
—
0
0
331
2971
1.14
1.36
2.5
3.2
2.45
2.46
mmol/l
1.21
280
2600
14
75
1.87
1.34
1.4
1.4
—
—
—
0
0
14
75
1.87
1.34
1.4
1.4
—
—
—
0
0
57
428
1.34
1.33
1.6
1.6
—
—
—
0
0
267
3000
0.87
1.31
4.1
4.0
36.98
402.21
ng/l
11.62
214
2545
168
1954
0.84
1.29
1.3
1.2
5.47
14.09
u/ml
2.08
59
694
122
1460
0.82
1.29
1.8
2.1
0.20
0.20
g/l
0.48
115
1357
40
553
0.72
1.29
1.3
1.8
39.05
38.04
u/l
0.11
33
480
29
425
0.68
1.29
2.9
3.1
0.93
0.85
nmol/l
0.29
18
330
175
2023
0.85
1.26
1.3
1.2
25.11
38.80
iu/ml
1.37
41
654
28
409
0.68
1.23
2.3
2.3
12.23
95.13
ug/min
3.48
13
244
135
1139
1.20
1.22
1.9
1.6
—
—
—
0
0
462
4259
1.12
1.22
3.8
3.4
0.40
0.48
e6/l
0.54
368
3333
5
19
2.64
1.21
1.2
1.8
108.60
94.11
%
—
5
19
138
1621
0.84
1.20
2.3
2.7
9.21
9.20
umol/l
0.00
120
1419
92
750
1.24
1.18
1.3
1.4
94.83
54.58
au/ml
—
6
48
27
393
0.68
1.18
1.3
1.7
—
—
—
0
0
43
317
1.37
1.15
2.2
1.6
—
—
—
0
0
224
1986
1.15
1.12
1.9
2.5
1.58
1.82
%
3.88
192
1738
585
5483
1.10
1.12
2.9
2.8
137.12
155.50
ug/l
1.04
504
4935
7
136
0.51
1.09
1.1
1.3
16.14
12.87
u/l
—
7
125
180
1574
1.16
1.09
4.9
7.6
122.13
121.04
g/l
0.32
174
1531
25
362
0.69
1.08
1.2
1.7
—
—
—
0
0
13
74
1.76
1.06
1.3
1.4
—
—
—
0
0
795
7574
1.09
1.05
12.8
18.3
1.25
1.35
inr
2.64
207
2127
18
277
0.65
1.05
1.1
1.8
—
—
—
0
0
6
125
0.48
1.04
1.2
1.2
7.50
7.57
mmol/l
—
6
105
208
1848
1.14
1.02
1.8
1.8
—
—
—
0
0
1024
9874
1.09
1.01
3.8
3.9
15.35
15.05
pmol/l
3.05
891
8735
25
172
1.46
1.00
2.7
2.6
—
—
—
0
0
20
297
0.67
0.99
1.1
1.3
—
365.00
—
0
8
98
1162
0.83
0.98
2.9
3.0
73.07
61.34
ml/min/173m2
2.11
41
498
187
1660
1.14
0.94
4.9
3.7
—
—
—
0
0
694
6604
1.08
0.92
3.5
4.8
35.21
34.67
g/l
1.74
628
6107
10
170
0.59
0.90
1.2
1.7
—
—
—
0
0
288
2636
1.11
0.89
3.4
2.9
1.93
1.08
e6/l
0.82
169
1566
329
3560
0.91
0.88
2.9
3.3
0.67
0.79
ug/l
3.62
241
2510
6
30
2.00
0.87
1.5
1.1
—
—
—
0
0
44
343
1.29
0.86
1.6
2.3
122.92
127.96
g/l
0.60
36
255
29
213
1.37
0.84
1.7
2.4
23.17
23.17
mg/l
—
6
52
19
274
0.69
0.84
1.1
1.1
—
—
—
0
0
28
377
0.74
0.84
1.2
1.7
—
—
—
0
0
8
138
0.58
0.83
1.4
2.0
3.01
4.55
mg/l
—
8
133
14
214
0.65
0.83
1.4
1.5
—
—
—
0
0
54
437
1.24
0.80
1.5
1.4
—
—
—
0
0
492
4642
1.08
0.80
4.0
3.5
24.80
91.36
e6/l
4.23
392
3668
10
58
1.73
0.79
1.1
1.4
1.50
1.56
g/l
—
10
58
0
25
0.00
0.79
0.0
1.1
—
18.06
—
0
18
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
10
161
0.62
0.75
1.1
1.7
—
—
—
0
0
19
267
0.71
0.75
1.4
1.4
—
—
—
0
0
21
290
0.72
0.75
1.3
1.4
0.76
0.81
nmol/l
0.12
14
230
8
133
0.60
0.73
1.9
1.4
10.50
13.78
u/l
—
8
125
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
166
1494
1.12
0.72
2.1
2.6
59.32
69.28
e9/l
4.53
134
1150
61
509
1.21
0.70
1.2
1.3
—
—
—
0
0
388
3646
1.08
0.70
3.8
4.0
86.13
85.10
%
0.36
381
3552
18
251
0.71
0.69
1.2
1.6
—
—
—
0
0
18
251
0.71
0.69
1.2
1.6
—
—
—
0
0
17
239
0.71
0.69
1.4
1.4
—
—
—
0
0
11
69
1.60
0.68
1.3
1.1
—
—
—
0
0
42
338
1.25
0.68
1.6
1.6
—
—
—
0
0
762
7898
0.94
0.67
6.7
9.0
4.20
4.25
e9/l
0.22
657
6873
7
120
0.58
0.67
1.4
1.6
—
—
—
0
0
204
2225
0.91
0.66
1.4
1.5
2.20
2.73
g/l
4.30
98
1274
22
162
1.36
0.66
1.5
1.3
0.98
0.36
nmol/l
1.89
13
14
20
145
1.38
0.66
1.5
1.3
—
—
—
0
0
61
514
1.19
0.65
2.3
2.4
38.81
37.17
g/l
1.50
50
450
475
4992
0.93
0.63
4.2
4.7
21.13
21.59
%
0.32
252
2633
596
6216
0.94
0.63
4.7
5.4
2.18
4.04
ug/l
1.98
521
5484
37
297
1.25
0.62
1.5
1.4
294.13
654.49
e6/l
0.42
31
240
37
297
1.25
0.62
1.4
1.3
1.46
39.29
e6/l
1.18
28
232
12
176
0.68
0.62
1.0
1.0
—
—
—
0
0
16
222
0.72
0.61
1.1
1.6
—
—
—
0
0
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
0
20
0.00
0.60
0.0
11.1
—
5.82
—
0
20
18
131
1.38
0.59
1.4
1.6
—
—
—
0
0
11
162
0.68
0.58
1.2
1.1
—
—
—
0
0
50
594
0.84
0.58
3.1
2.7
—
—
—
0
0
8
53
1.51
0.58
1.6
1.8
3.96
8.18
nmol/l
—
8
44
0
23
0.00
0.58
0.0
1.2
—
24.50
—
0
14
140
1267
1.11
0.58
3.1
4.1
1.23
1.22
mmol/l
0.33
121
1089
14
98
1.43
0.56
1.2
1.7
—
—
—
0
0
12
172
0.70
0.56
1.3
1.7
—
—
—
0
0
13
90
1.45
0.55
1.5
1.4
—
—
—
0
0
13
90
1.45
0.55
1.5
1.4
—
—
—
0
0
16
217
0.73
0.55
1.5
1.5
—
—
—
0
0
11
74
1.49
0.53
1.1
1.4
0.90
0.95
g/l
0.27
11
74
64
554
1.16
0.53
2.2
2.6
0.11
1.50
g/l
7.76
52
478
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
12
168
0.71
0.50
1.2
1.5
—
—
—
0
0
12
168
0.71
0.50
1.2
1.5
—
—
—
0
0
12
168
0.71
0.50
1.4
1.2
4.40
3.39
u/ml
—
5
51
1314
13333
0.94
0.50
19.4
17.0
26.51
26.81
mg/l
0.11
1107
10818
29
356
0.81
0.49
2.8
3.4
434.42
1098.76
u/ml
0.41
29
332
37
442
0.83
0.48
2.5
3.5
26.52
25.23
mmol/l
1.65
37
435
131
1200
1.10
0.46
1.7
2.2
376.99
369.36
nmol/l
0.18
112
1080
5
81
0.62
0.45
1.6
1.4
0.60
2.91
u/field
—
5
57
24
193
1.25
0.43
1.9
7.3
7.38
7.67
mmol/l
0.18
19
163
84
755
1.12
0.43
2.0
2.5
0.65
0.65
%
0.06
84
750
6
94
0.64
0.42
1.2
1.2
—
—
—
0
0
13
173
0.75
0.42
6.6
3.9
—
—
—
0
0
152
1410
1.09
0.42
1.9
2.8
66.02
66.36
g/l
0.24
122
1285
22
272
0.81
0.41
3.1
3.9
5.29
1.40
%
0.76
17
241
21
261
0.80
0.41
1.4
1.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
4.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
25
204
1.23
0.40
1.2
1.4
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.4
—
0.69
—
0
12
7
101
0.69
0.39
1.0
1.1
—
—
—
0
0
82
741
1.11
0.39
1.9
1.9
1.17
1.89
ug/l
0.67
65
646
67
599
1.12
0.38
2.2
2.5
2.88
3.01
g/l
0.48
56
534
35
299
1.17
0.37
1.5
1.4
—
—
—
0
0
110
1013
1.09
0.37
1.4
2.2
12.82
12.48
nmol/l
0.18
97
882
29
343
0.84
0.36
1.4
1.6
1.96
4.39
mg/l
0.87
23
268
23
277
0.83
0.35
2.3
3.4
58.22
59.95
%
0.30
23
277
9
122
0.74
0.35
1.1
1.1
—
48.91
—
0
11
469
4539
1.05
0.35
2.3
2.6
53.62
77.80
u/l
0.75
424
4152
37
425
0.87
0.34
1.2
1.2
0.24
0.84
u/ml
—
5
41
6
45
1.33
0.33
1.8
1.7
29.22
201.59
ug/l
—
6
38
11
142
0.77
0.30
1.1
1.6
—
—
—
0
0
11
142
0.77
0.30
1.1
1.6
—
—
—
0
0
11
142
0.77
0.30
1.1
1.6
—
—
—
0
0
794
8093
0.97
0.30
2.9
3.2
45.74
56.28
u/l
1.36
707
7363
42
473
0.89
0.30
1.0
1.0
—
—
—
0
0
636
6506
0.96
0.29
5.6
6.1
25.03
26.28
%
2.13
579
6045
10
130
0.77
0.29
1.2
1.7
—
—
—
0
0
7
56
1.25
0.29
1.4
1.0
—
—
—
0
0
33
376
0.88
0.28
2.2
3.2
8.03
7.79
kpa
0.57
33
366
256
2459
1.05
0.27
1.2
1.2
1.35
1.59
u/ml
0.19
65
610
67
614
1.09
0.27
2.2
2.5
9.12
10.55
g/l
3.29
56
546
625
6386
0.97
0.27
5.4
5.8
60.12
58.30
%
3.31
569
5933
9
121
0.74
0.27
1.1
1.1
—
59.00
—
0
5
9
121
0.74
0.27
1.2
1.1
89.89
95.99
%
—
9
115
1228
12152
1.04
0.26
4.8
4.7
1.94
2.12
mu/l
0.97
1077
10831
257
2473
1.05
0.26
3.7
3.1
2.35
1.94
e6/l
0.35
137
1410
21
178
1.18
0.26
1.4
1.5
—
—
—
0
0
21
178
1.18
0.26
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
77
1.30
0.26
1.4
1.2
—
—
—
0
0
148
1404
1.06
0.26
3.9
6.5
1.23
1.42
mmol/l
1.43
141
1367
11
138
0.80
0.25
1.2
1.1
—
—
—
0
0
10
127
0.79
0.25
1.2
1.1
—
—
—
0
0
47
425
1.11
0.25
1.4
1.5
290.81
273.34
ug/g
0.25
31
256
9
75
1.20
0.25
1.7
2.3
—
—
—
0
0
70
647
1.09
0.25
2.1
2.5
3.56
3.72
g/l
0.64
60
582
72
667
1.08
0.24
2.5
3.3
4.40
4.34
pmol/l
0.24
65
580
70
648
1.08
0.24
2.1
2.5
6.86
7.45
g/l
2.90
59
583
70
648
1.08
0.24
2.1
2.5
—
—
—
0
0
6
81
0.74
0.24
1.0
1.9
—
—
—
0
0
23
265
0.87
0.24
2.2
3.2
3.95
4.49
e9/l
0.83
23
265
6
85
0.70
0.24
1.2
1.8
—
—
—
0
0
6
85
0.70
0.24
1.2
1.8
—
—
—
0
0
21
180
1.17
0.23
1.4
1.5
—
—
—
0
0
21
180
1.17
0.23
1.4
1.5
—
—
—
0
0
37
332
1.12
0.23
1.8
2.8
25.81
34.02
umol/l
2.70
32
297
126
1328
0.94
0.23
2.5
2.3
59.99
37.91
u/l
0.35
103
1131
145
1522
0.95
0.23
2.7
3.5
2.79
2.05
mmol/l
1.75
118
1249
21
181
1.16
0.22
1.4
1.5
—
—
—
0
0
113
1193
0.94
0.22
2.6
3.8
70.71
96.24
ng/l
4.62
82
1022
33
368
0.89
0.22
7.6
6.9
106.39
105.40
mmol/l
0.67
28
334
132
1256
1.06
0.22
2.5
2.9
4.43
4.50
kpa
0.17
127
1212
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
37
335
1.11
0.20
1.8
2.7
16.19
15.80
%
0.22
22
169
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
0.11
—
0
7
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.2
1.1
—
—
—
0
0
9
113
0.80
0.20
1.2
1.0
—
—
—
0
0
9
115
0.78
0.20
2.2
2.2
—
—
—
0
0
6
51
1.18
0.19
1.5
1.3
—
—
—
0
0
16
137
1.17
0.18
2.3
2.0
3.60
2.08
u/field
—
5
48
31
280
1.11
0.18
1.5
1.7
—
—
—
0
0
20
227
0.88
0.18
1.1
1.1
—
—
—
0
0
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
24
268
0.89
0.17
1.4
1.8
8.70
5.10
iu/l
—
7
85
121
1263
0.95
0.17
1.2
1.4
—
—
—
0
0
12
141
0.85
0.16
1.0
1.1
—
—
—
0
0
38
350
1.09
0.16
3.4
3.8
35.27
28.28
mg/l
0.32
21
221
6
79
0.76
0.15
2.8
3.8
—
—
—
0
0
249
2428
1.03
0.15
2.2
2.0
30.03
30.04
s
0.00
241
2349
12
102
1.18
0.15
1.2
1.3
—
—
—
0
0
148
1531
0.96
0.15
2.7
3.5
5.84
5.84
kpa
0.00
142
1482
7
90
0.78
0.14
1.6
1.6
—
—
—
0
0
7
90
0.78
0.14
1.6
1.6
—
—
—
0
0
20
179
1.12
0.14
1.5
1.5
—
—
—
0
0
9
109
0.82
0.13
1.4
1.5
—
—
—
0
0
36
386
0.93
0.13
1.6
1.5
—
—
—
0
0
55
579
0.95
0.12
1.9
3.6
23.14
85.96
mg/l
1.90
47
476
48
507
0.95
0.11
1.2
1.3
—
—
—
0
0
55
578
0.95
0.11
1.9
3.6
48.51
64.44
mg/l
0.53
47
473
14
157
0.89
0.11
1.1
1.1
116.79
116.39
%
0.02
14
145
760
7663
0.99
0.10
3.8
6.3
11.48
11.97
umol/l
0.53
706
7250
19
173
1.10
0.10
1.4
1.5
—
—
—
0
0
16
177
0.90
0.10
3.6
3.8
63.36
55.42
%
1.13
11
151
90
870
1.04
0.10
4.7
8.8
25.24
24.33
mmol/l
1.88
85
840
5
44
1.14
0.10
1.0
1.0
93.80
98.17
%
—
5
36
43
451
0.95
0.08
2.1
1.7
—
—
—
0
0
6
56
1.07
0.08
1.8
2.6
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
—
1.05
—
0
18
6
56
1.07
0.08
1.8
2.6
—
—
—
0
0
15
136
1.10
0.08
1.1
1.3
—
—
—
0
0
71
686
1.04
0.08
5.4
5.0
1.52
1.60
%
0.32
65
648
6
58
1.03
0.08
1.3
1.2
—
65.71
%
—
0
7
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
18
166
1.09
0.07
1.2
1.4
—
—
—
0
0
6
73
0.82
0.07
1.0
1.1
—
—
—
0
0
212
2152
0.98
0.07
2.2
2.6
21.74
22.21
%
0.17
177
1834
1100
10957
1.01
0.07
5.6
7.8
79.48
80.31
u/l
0.28
1000
10233
246
2491
0.99
0.06
2.4
3.1
0.83
0.82
mmol/l
0.98
226
2332
39
375
1.04
0.05
1.2
1.2
—
—
—
0
0
130
1278
1.02
0.05
1.9
2.1
186.53
161.47
ug/g
0.36
102
1009
39
378
1.03
0.04
1.2
1.2
—
—
—
0
0
1015
10173
0.99
0.03
3.9
4.2
12.04
14.06
mm/h
4.45
906
9282
243
2447
0.99
0.03
2.2
2.6
11.96
12.36
umol/l
0.36
215
2268
67
659
1.02
0.02
1.4
1.2
207.25
212.39
u/ml
0.03
61
595
35
341
1.03
0.02
1.4
1.4
—
—
—
0
0
35
341
1.03
0.02
1.4
1.4
—
—
—
0
0
43
422
1.02
0.01
1.6
1.5
—
—
—
0
0
26
253
1.03
0.01
1.2
1.4
—
—
—
0
0
20
195
1.03
0.00
1.8
1.6
46.73
64.62
%
1.27
14
125
26
265
0.98
0.00
1.8
2.0
1.85
1.68
mmol/l
0.27
26
259
81
815
0.99
0.00
1.6
1.8
1.61
1.54
g/l
0.24
65
700
14
144
0.97
0.00
1.1
1.4
196.75
264.47
pmol/l
—
8
126
227
2266
1.00
0.00
2.1
2.6
2.31
2.27
g/l
0.45
195
2088
23
232
0.99
0.00
1.5
1.3
—
—
—
0
0
7
78
0.90
0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
6
67
0.90
0.00
1.3
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
79
0.89
-0.00
1.4
1.5
93.29
89.61
umol/l
—
7
79
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
6
64
0.94
-0.00
1.3
2.1
718.00
1507.61
u/ml
—
6
64
8
85
0.94
-0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
66
0.91
-0.00
1.2
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
69
1.01
-0.00
1.1
1.3
128.87
153.92
pmol/l
—
7
69
7
69
1.01
-0.00
3.1
3.4
300.00
218.07
u/l
—
7
69
5
56
0.89
-0.00
2.8
2.8
23.00
30.62
umol/l
—
5
37
6
69
0.87
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.66
—
0
5
7
75
0.93
-0.00
1.0
1.2
—
—
—
0
0
8
86
0.93
-0.00
1.1
1.1
—
—
—
0
0
8
86
0.93
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
377.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
-0.00
1.1
1.1
—
—
—
0
0
8
85
0.94
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
7
75
0.93
-0.00
1.0
1.2
—
—
—
0
0
6
66
0.91
-0.00
1.2
2.0
—
—
—
0
0
9
92
0.98
-0.00
1.9
3.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_SELEGILINE – Use of selegiline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).